was read the article
array:24 [ "pii" => "S141386701930488X" "issn" => "14138670" "doi" => "10.1016/j.bjid.2019.11.004" "estado" => "S300" "fechaPublicacion" => "2020-01-01" "aid" => "946" "copyright" => "Sociedade Brasileira de Infectologia" "copyrightAnyo" => "2019" "documento" => "article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "fla" "cita" => "Braz J Infect Dis. 2020;24:7-12" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 194 "formatos" => array:3 [ "EPUB" => 29 "HTML" => 95 "PDF" => 70 ] ] "itemSiguiente" => array:19 [ "pii" => "S1413867019304854" "issn" => "14138670" "doi" => "10.1016/j.bjid.2019.11.003" "estado" => "S300" "fechaPublicacion" => "2020-01-01" "aid" => "944" "copyright" => "Sociedade Brasileira de Infectologia" "documento" => "article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "fla" "cita" => "Braz J Infect Dis. 2020;24:13-24" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 159 "formatos" => array:3 [ "EPUB" => 23 "HTML" => 75 "PDF" => 61 ] ] "en" => array:12 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original article</span>" "titulo" => "Differential replicative fitness of the four dengue virus serotypes circulating in Colombia in human liver Huh7 cells" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "13" "paginaFinal" => "24" ] ] "contieneResumen" => array:1 [ "en" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1250 "Ancho" => 1508 "Tamanyo" => 160925 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0005" "detalle" => "Fig. " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Reverse transcriptase polymerase chain reaction (RT-PCR) with viral RNA from dengue virus clinical isolates for genotyping fragments of DENV-1 S24, DENV-1 116, DENV-S33, DENV-2 S3, DENV-2 216, DENV-2 209, DENV-3 S7, DENV-3 S8, DENV-3 S26, DENV-4 S29, DENV-4 416, DENV-S32. The amplification products of the expected size (775<span class="elsevierStyleHsp" style=""></span>bp) were resolved in 2% agarosa gel stained with ethidium bromide.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Hernando Gutiérrez-Barbosa, Nadia Y. Castañeda, Jaime E. Castellanos" "autores" => array:3 [ 0 => array:2 [ "nombre" => "Hernando" "apellidos" => "Gutiérrez-Barbosa" ] 1 => array:2 [ "nombre" => "Nadia Y." "apellidos" => "Castañeda" ] 2 => array:2 [ "nombre" => "Jaime E." "apellidos" => "Castellanos" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1413867019304854?idApp=UINPBA00003Y" "url" => "/14138670/0000002400000001/v3_202004030701/S1413867019304854/v3_202004030701/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S1413867020300015" "issn" => "14138670" "doi" => "10.1016/j.bjid.2020.01.001" "estado" => "S300" "fechaPublicacion" => "2020-01-01" "aid" => "953" "copyright" => "Sociedade Brasileira de Infectologia" "documento" => "article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "fla" "cita" => "Braz J Infect Dis. 2020;24:1-6" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 120 "formatos" => array:3 [ "EPUB" => 17 "HTML" => 76 "PDF" => 27 ] ] "en" => array:12 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original article</span>" "titulo" => "Seroprevalence of chikungunya virus infection in five hospitals within Anyigba, Kogi State of Nigeria" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "1" "paginaFinal" => "6" ] ] "contieneResumen" => array:1 [ "en" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1037 "Ancho" => 1507 "Tamanyo" => 85548 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0005" "detalle" => "Fig. " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Prevalence of CHIKV antibodies in febrile patients in Anyigba according to age group.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Cornelius A. Omatola, Bernard A. Onoja, Peter K. Fassan, Stephanie A. Osaruyi, Mercy Iyeh, Matthew A. Samuel, Peace U. Haruna" "autores" => array:7 [ 0 => array:2 [ "nombre" => "Cornelius A." "apellidos" => "Omatola" ] 1 => array:2 [ "nombre" => "Bernard A." "apellidos" => "Onoja" ] 2 => array:2 [ "nombre" => "Peter K." "apellidos" => "Fassan" ] 3 => array:2 [ "nombre" => "Stephanie A." "apellidos" => "Osaruyi" ] 4 => array:2 [ "nombre" => "Mercy" "apellidos" => "Iyeh" ] 5 => array:2 [ "nombre" => "Matthew A." "apellidos" => "Samuel" ] 6 => array:2 [ "nombre" => "Peace U." "apellidos" => "Haruna" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1413867020300015?idApp=UINPBA00003Y" "url" => "/14138670/0000002400000001/v3_202004030701/S1413867020300015/v3_202004030701/en/main.assets" ] "en" => array:19 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Original article</span>" "titulo" => "Clinical and microbiological characteristics of cryptococcosis at an university hospital in China from 2013 to 2017" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "7" "paginaFinal" => "12" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Lan-fang Fang, Piao-piao Zhang, Jie Wang, Qing Yang, Ting-ting Qu" "autores" => array:5 [ 0 => array:3 [ "nombre" => "Lan-fang" "apellidos" => "Fang" "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">1</span>" "identificador" => "fn0005" ] ] ] 1 => array:3 [ "nombre" => "Piao-piao" "apellidos" => "Zhang" "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">1</span>" "identificador" => "fn0005" ] ] ] 2 => array:3 [ "nombre" => "Jie" "apellidos" => "Wang" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] 3 => array:3 [ "nombre" => "Qing" "apellidos" => "Yang" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] ] ] 4 => array:4 [ "nombre" => "Ting-ting" "apellidos" => "Qu" "email" => array:1 [ 0 => "qutingting@zju.edu.cn" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] ] "afiliaciones" => array:2 [ 0 => array:3 [ "entidad" => "Zhejiang University School of Medicine, The First Affiliated Hospital, State Key Laboratory for Diagnosis and Treatment of Infectious Disease, Hangzhou, Zhejiang, China" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Zhejiang University School of Medicine, The First Affiliated Hospital, Respiratory Department, Hangzhou, Zhejiang, China" "etiqueta" => "b" "identificador" => "aff0010" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "<span class="elsevierStyleItalic">Corresponding author at</span>: 79# Qingchun East Road, Hangzhou 310001, China." ] ] ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:8 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 2103 "Ancho" => 3169 "Tamanyo" => 207046 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0005" "detalle" => "Fig. " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Trends in fluconazole susceptibility of cryptococcal isolates from 2013 to 2017.</p>" ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0035">Introduction</span><p id="par0005" class="elsevierStylePara elsevierViewall">Cryptococcosis is a significant invasive fungal infection with noteworthy morbidity and mortality, primarily caused by <span class="elsevierStyleItalic">Cryptococcus neoformans</span> (<span class="elsevierStyleItalic">C. neoformans</span>)and <span class="elsevierStyleItalic">Cryptococcus gattii</span>.<a class="elsevierStyleCrossRefs" href="#bib0005"><span class="elsevierStyleSup">1,2</span></a> Although cryptococcosis may occur in healthy hosts,<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a> the majority of infections occur in patients with significant underlying predisposing factors, such as organ transplantation, hematologic malignancies, and advanced human immunodeficiency virus (HIV) disease.<a class="elsevierStyleCrossRefs" href="#bib0010"><span class="elsevierStyleSup">2,4–8</span></a> In Europe and the in United States about 80% of the cryptococcosis cases were associated with HIV/AIDS.<a class="elsevierStyleCrossRefs" href="#bib0010"><span class="elsevierStyleSup">2,9</span></a> Nonetheless, in China, the majority of patients with cryptococcosis are not infected with HIV.<a class="elsevierStyleCrossRefs" href="#bib0050"><span class="elsevierStyleSup">10,11</span></a> This infection has been increasing steadily over the past years in China.</p><p id="par0010" class="elsevierStylePara elsevierViewall">In recent years, there is a growing concern among clinicians regarding the potential for the emergence of antifungal resistance among <span class="elsevierStyleItalic">C. neoformans</span> because of high rates of fungal persistence and frequent disease relapse.<a class="elsevierStyleCrossRefs" href="#bib0060"><span class="elsevierStyleSup">12–14</span></a> Several reports on the emergence of resistance to amphotericin B, fluconazole, flucytosine, or itraconazole in <span class="elsevierStyleItalic">C. neoformans</span> during treatment has been published.<a class="elsevierStyleCrossRefs" href="#bib0075"><span class="elsevierStyleSup">15,16</span></a> Consequently, widespread increase in fluconazole resistance among <span class="elsevierStyleItalic">C. neoformans</span> became a public health concern calling for more-widespread surveillance. However, studies on the trends in antifungal drug susceptibility of <span class="elsevierStyleItalic">Cryptococcus</span> are limited in China. In 2016, Fan et al. reported a proportional increase of cryptococcal isolates with non-wild-type MICs to fluconazole (non-WT, MIC<span class="elsevierStyleHsp" style=""></span>><span class="elsevierStyleHsp" style=""></span>8<span class="elsevierStyleHsp" style=""></span>μg/ml) in China from 2009 to 2014,<a class="elsevierStyleCrossRef" href="#bib0075"><span class="elsevierStyleSup">15</span></a> but clinical characteristics of these cryptococcal isolates were not collected. Now, the trend in antifungal drug susceptibility of clinical <span class="elsevierStyleItalic">Cryptococcus</span> strains in China is still uncertain, and further research on the correlation of the antifungal drug susceptibility trend and clinical outcomes is necessary.</p><p id="par0015" class="elsevierStylePara elsevierViewall">In this study, we analyzed the trends in antifungal drug susceptibility of 217 consecutive cryptococcal isolates from a medical center in China between 2013 and 2017, of which 98 isolates were conserved for molecular evaluation. The present study also assessed the clinical manifestations of the 98 patients during the study period.</p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0040">Material and methods</span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0045">Cryptococcal isolates</span><p id="par0020" class="elsevierStylePara elsevierViewall">This was a cross-sectional retrospective study in a 2500-bed teaching hospital in east China. A total of 217 non-repetitive <span class="elsevierStyleItalic">Cryptococcus</span> clinical strains were consecutively isolated from <span class="elsevierStyleItalic">Cryptococcus</span> culture-proven patients from 2013 to 2017 in this hospital. Antifungal drug susceptibility was detected for all 217 clinical strains.</p><p id="par0025" class="elsevierStylePara elsevierViewall">Out of these 217 strains, 98 isolates were randomly selected and stored in 25% glycerol at –80<span class="elsevierStyleHsp" style=""></span>°C until use and were maintained on yeast peptone dextrose (1% yeast extract, 2% peptone, 2% glucose) agar at 25<span class="elsevierStyleHsp" style=""></span>°C for species identification and MLST during this study.</p></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0050">Antifungal susceptibility studies</span><p id="par0030" class="elsevierStylePara elsevierViewall">The antifungal drug susceptibility of the total 217 <span class="elsevierStyleItalic">Cryptococcus</span> strains was detected by ATB FUNGUS 3 kit (BioMérieux France). <span class="elsevierStyleItalic">Candida krusei</span> ATCC 6258 and <span class="elsevierStyleItalic">Candida parapsilosis</span> ATCC 22019 were used as quality control organisms. The interpretive criteria for susceptibility to fluconazole and flucytosine were according to the manufacturer’s instructions of ATB FUNGUS 3 kit. For fluconazole: susceptible, 4<span class="elsevierStyleHsp" style=""></span>μg/ml; susceptible dose dependent, 8<span class="elsevierStyleHsp" style=""></span>μg/ml; resistant, 16<span class="elsevierStyleHsp" style=""></span>μg/ml; and for flucytosine, susceptible, 4<span class="elsevierStyleHsp" style=""></span>μg/ml; intermediate, 8–16<span class="elsevierStyleHsp" style=""></span>μg/ml; resistant, 32<span class="elsevierStyleHsp" style=""></span>μg/ml. As there are currently no standard clinical breakpoints for <span class="elsevierStyleItalic">Cryptococcus spp.</span>, we used the epidemiological cut-off values as recommended by previous studies: voriconazole, 0.125<span class="elsevierStyleHsp" style=""></span>μg/ml; itraconazole, 0.25<span class="elsevierStyleHsp" style=""></span>μg/ml; and amphotericin B, 1<span class="elsevierStyleHsp" style=""></span>μg/ml.<a class="elsevierStyleCrossRefs" href="#bib0075"><span class="elsevierStyleSup">15,17,18</span></a></p></span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0055">DNA extraction</span><p id="par0035" class="elsevierStylePara elsevierViewall">Among the 98 conserved clinical cryptococcal strains genomic DNA was extracted usin a commercial kit (Sangon Biotech Co., Ltd, Shanghai, China).</p></span><span id="sec0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0060">Identification of <span class="elsevierStyleItalic">Cryptococcus</span> species and variety</span><p id="par0040" class="elsevierStylePara elsevierViewall">Amplification of the rDNA internal transcribed spacer (ITS) region was performed as previously described.<a class="elsevierStyleCrossRefs" href="#bib0075"><span class="elsevierStyleSup">15,19</span></a> The PCR products were sequenced in both directions using the DNA analyzer ABI 3730XL system (Applied Biosystems, Foster City, CA). The obtained ITS sequences of <span class="elsevierStyleItalic">Cryptococcus</span> isolates were compared against those contained in the Centraalbureau voor Schimmelcultures (CBS) Fungal Biodiversity Centre database by using BIOLOMICSNET software (<a href="http://www.cbs.knaw.nl/collections/BioloMICSSequences.aspx)">http://www.cbs.knaw.nl/collections/BioloMICSSequences.aspx)</a>.</p><p id="par0045" class="elsevierStylePara elsevierViewall">Bruker Biotyper MALDI-TOF MS (Bruker, Daltonik, Bremen, Germany) was also used to identify the conserved 98 <span class="elsevierStyleItalic">Cryptococcus</span> clinical strains. According to the manufacture’s recommendations and as Buchan et al. described, 16 identification by plate-grown isolates (on-plate protein extraction method) was applied. The procedure was performed as previously reported.<a class="elsevierStyleCrossRef" href="#bib0075"><span class="elsevierStyleSup">15</span></a></p></span><span id="sec0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0065">Multilocus sequence typing (MLST) and mating type analysis</span><p id="par0050" class="elsevierStylePara elsevierViewall">For MLST analysis, DNA fragments of seven unlinked genes that included IGS1, GPD1, CAP59, URA5, PLB1, LAC1, and SOD1 were amplified by PCR from the 98 preserved <span class="elsevierStyleItalic">Cryptococcus</span> clinical strains. Alleles and sequence types (STs) were assigned by using the fungal MLST database (<a href="http://mlst.mycologylab.org/">http://mlst.mycologylab.org/</a>). Molecular types (i.e., VNI to VNIV for <span class="elsevierStyleItalic">C. neoformans</span> and VGI to VGIV for <span class="elsevierStyleItalic">C. gattii</span>) were assigned according to isolates' STs and were queried against the online MLST database (<a href="http://mlst.mycologylab.org">http://mlst.mycologylab.org</a>).</p></span><span id="sec0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0070">Patient selection and data collection</span><p id="par0055" class="elsevierStylePara elsevierViewall">Clinical characteristics of the 98 cryptococcosis patients with positive <span class="elsevierStyleItalic">Cryptococcus</span> culture were retrospectively evaluated. Demographic and clinical data including predisposing factors, infection types and outcome, were abstracted from the electronic record.</p></span><span id="sec0045" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0075">Statistical analysis</span><p id="par0060" class="elsevierStylePara elsevierViewall">The Statistical Package for the Social Sciences (SPSS, Version 22.0, Chicago, IL, USA) was used for the analysis. Two groups (HIV and non-HIV patients) were specified and investigated. Descriptive data are reported as either mean<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>SD, median (interquartile range) or number and percentage. Difference between continuous variables was compared by Student's <span class="elsevierStyleItalic">t</span>-test and non-parametrical tests. Categorical variables were compared by chi-square analysis. A <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>0.05 was considered statistically significant.</p></span><span id="sec0050" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0080">Ethics and consent statements</span><p id="par0065" class="elsevierStylePara elsevierViewall">This was a retrospective study. All isolates present in this study had been stored in the Department of Microbiology, the First Affiliated Hospital, Zhejiang University School of Medicine, China. The Institutional Review Board of the First Affiliated Hospital, College of Medicine, Zhejiang University waived the need for informed consent and granted permission to use the strains to perform all experiments in this study.</p></span></span><span id="sec0055" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0085">Results</span><span id="sec0060" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0090">Microbiologic characterization of the cryptococcal isolates</span><span id="sec0065" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0095">Trends in antifungal drug susceptibility of 217 cryptococcal isolates from 2013 to 2017</span><p id="par0070" class="elsevierStylePara elsevierViewall"><a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a> summarizes the <span class="elsevierStyleItalic">in vitro</span> susceptibilities to the five antifungal agents in use (amphotericin B, fluconazole, flucytosine, itraconazole, and voriconazole) of the 217 <span class="elsevierStyleItalic">Crypyococcus</span> isolated at an university hospital between 2013 and 2017. All of the 217 <span class="elsevierStyleItalic">Crypyococcus</span> isolates were highly susceptible to amphotericin B (99.1% susceptible) over the entire 5-year period. Also, it was shown that susceptibility to fluconazole decreased from 1.0% in 2013 to 75.0% in 2017. The MIC range of fluconazole showed gradual increasing trend shifting from 1 to 4<span class="elsevierStyleHsp" style=""></span>μg/ml in 2013–2014 to 1–8<span class="elsevierStyleHsp" style=""></span>μg/ml in 2015, and to 1–16<span class="elsevierStyleHsp" style=""></span>μg/ml in 2016–2017 (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>).</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><elsevierMultimedia ident="fig0005"></elsevierMultimedia></span></span><span id="sec0070" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0100">Identification, multilocus sequence typing (MLST) and molecular types</span><p id="par0075" class="elsevierStylePara elsevierViewall">According to MALDI-TOF MS results, the conserved 98 clinical <span class="elsevierStyleItalic">c</span>ryptococcal strains included 97<span class="elsevierStyleHsp" style=""></span><span class="elsevierStyleItalic">C. neoformans</span>strains (96 <span class="elsevierStyleItalic">var. grubii</span> strains and one var. neoformans strain) and one <span class="elsevierStyleItalic">C. gattii</span> strain, which are consistent with the rDNA ITS region amplification results. rDNA ITS region amplification are in agreement with those of MALDI-TOF MS.</p><p id="par0080" class="elsevierStylePara elsevierViewall">MLST and molecular type results of the 98 clinical cryptococcal isolates are shown in <a class="elsevierStyleCrossRef" href="#tbl0010">Table 2</a>. MLST analysis revealed that all 98 cryptococcal isolates belonged to six sequence types, including ST5 (90 isolates, 91.8%), ST31 (3 isolates, 3.1%), ST81 (2 isolates, 2.0%), ST326 (1 isolates, 1.0%), ST328 (1 isolates, 1.0%), and ST359 (1 isolates, 1.0%). Molecular type VNI (<span class="elsevierStyleItalic">var. grubii</span>) was recovered in 96 clinical cryptococcal isolates belonging to ST5, ST31, ST81, and ST359. The type VGII <span class="elsevierStyleItalic">(C. gattii</span>) was found in one clinical cryptococcal isolate belonging to ST328. While the type VNⅣ (<span class="elsevierStyleItalic">var. neoformans</span>) was found in one clinical cryptococcal isolate belonging to ST326.</p><elsevierMultimedia ident="tbl0010"></elsevierMultimedia></span><span id="sec0075" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0105">Patients’ characteristics</span><p id="par0085" class="elsevierStylePara elsevierViewall">Demographic data and clinical characteristics of the 98 <span class="elsevierStyleItalic">Cryptococcus</span> culture-proven patients of the study are shown in <a class="elsevierStyleCrossRef" href="#tbl0015">Table 3</a>. Among the 98 patients with cryptococcosis, 28 (28.6%) were male HIV-infected patients and 70 (71.4%) non-HIV-infected patients. There was no apparent sex difference in non-HIV-infected patients with cryptococcosis. HIV-infected patients were younger than non-infected patients (38.4<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>2.4 vs 50.7<span class="elsevierStyleHsp" style=""></span>±<span class="elsevierStyleHsp" style=""></span>1.7 years). Seventeen (13.7%) patients were on corticosteroids or immunosuppressives, 12 (12.2%) patients hag undergone organ transplantation, diabetes mellitus was found in nine (9.2%) patients, but 32 (32.7%) had no underlying diseases.</p><elsevierMultimedia ident="tbl0015"></elsevierMultimedia><p id="par0090" class="elsevierStylePara elsevierViewall">Among the 70 non-HIV-infected patients with cryptococcosis, 43 (61.4%) patients were diagnosed as cryptococcal meningitis, 17 (17/70, 24.3%) with pulmonary cryptococcosis, and eight (11.4%) patients with disseminated cryptococcosis. However, the incidence rate of disseminated cryptococcosis among the 28 HIV-infected patients was 35.7% (10/28), significantly higher than that in the 70 non-HIV-infected group (p<span class="elsevierStyleHsp" style=""></span><<span class="elsevierStyleHsp" style=""></span>0.05). Except for the 10 HIV-infected patients infected with disseminated cryptococcosis, the remaining 18 HIV-infected patients were all diagnosed as cryptococcal meningitis. The overall mortality rate was 18.4%, but higher among HIV-infected patients (28.6%) than in non-HIV-infected patients (<span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.147), <a class="elsevierStyleCrossRef" href="#tbl0015">Table 3</a>.</p></span></span><span id="sec0080" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0110">Discussion</span><p id="par0095" class="elsevierStylePara elsevierViewall">In the past years, the incidence of cryptococcosis in China is on the rise, and the fungal persistence and frequent disease relapse of cryptococcosis is the main clinical problem. Several reports of the emergence of resistance to the antifungal agents in HIV-infected patients have been published.<a class="elsevierStyleCrossRefs" href="#bib0060"><span class="elsevierStyleSup">12,16,20</span></a> However, in China, cryptococcosis mostly occurs in patients without HIV infection, and there are limited data on the molecular epidemiology of cryptococcosis in China. In our study, the susceptibility to the five antifungal agents in use (amphotericin B, fluconazole, flucytosine, itraconazole, and voriconazole) of 217 cryptococcal isolates from patients admitted to an university hospital between 2013 and 2017 were evaluated. The trend in the MIC range of fluconazole showed gradual increase from 2013 to 2017, while 16 <span class="elsevierStyleItalic">C. neoformans</span> strains were dose-dependent susceptible to fluconazole (MIC 8<span class="elsevierStyleHsp" style=""></span>μg/ml) and five <span class="elsevierStyleItalic">C. neoformans</span> strains with non-wild-type MICs to fluconazole (MIC 16<span class="elsevierStyleHsp" style=""></span>μg/ml) were detected in 2016–2017. This phenomenon was worth to be conveyed to clinicians, especially in cryptococcosis cases with fungal persistence and relapse. The Infectious Diseases Society of America (IDSA) recommends amphotericin B and 5-flucytosine as the preferred agents for the induction therapy, whereas the azoles (especially fluconazole) are used in the consolidation and maintenance phases of therapy, or as primary prophylaxis.<a class="elsevierStyleCrossRef" href="#bib0105"><span class="elsevierStyleSup">21</span></a> However, in resource limited settings, azoles are often used as initial therapy.<a class="elsevierStyleCrossRef" href="#bib0110"><span class="elsevierStyleSup">22</span></a> In the past years in our hospital, a relatively low fluconazole dose (400<span class="elsevierStyleHsp" style=""></span>mg per day and even 200<span class="elsevierStyleHsp" style=""></span>mg per day) was commonly administrated for therapy or prophylaxis of fungal infection, which might lead to the gradual upward MIC drifts of fluconazole. In several reports, high-dose of fluconazole (800<span class="elsevierStyleHsp" style=""></span>mg per day or even 1200<span class="elsevierStyleHsp" style=""></span>mg per day) was confirmed more efficacious to treat cryptococcosis.<a class="elsevierStyleCrossRefs" href="#bib0110"><span class="elsevierStyleSup">22,23</span></a> Higher doses of fluconazole and longer durations of treatment are suggested.<a class="elsevierStyleCrossRefs" href="#bib0105"><span class="elsevierStyleSup">21,23</span></a> The gradual upward MIC drifts of fluconazole might also explain the reason that some patients with cryptococcosis were cured or improved with higher dose of fluconazole. Amphotericin B maintained 1.0% susceptibility in the period of 2013–2016, but one isolate was shown to be resistant to amphotericin B (MIC 8<span class="elsevierStyleHsp" style=""></span>μg/ml) in 2017.</p><p id="par0100" class="elsevierStylePara elsevierViewall">As the results of species and varieties identification by MALDI-TOF MS and ITS sequencing, the conserved 98 clinical cryptococcal strains included 97 <span class="elsevierStyleItalic">C. neoformans</span>strains (96 <span class="elsevierStyleItalic">var. grubii</span> strains and one <span class="elsevierStyleItalic">var. neoformans</span> strain) and one <span class="elsevierStyleItalic">C. gattii</span> strain. Analysis of MLST showed that 91.8% of the isolates belonged to ST5 genotype VNI, which was the main ST of clinical <span class="elsevierStyleItalic">C. neoformans</span> in China, consistent with the related reports.<a class="elsevierStyleCrossRef" href="#bib0075"><span class="elsevierStyleSup">15</span></a><span class="elsevierStyleItalic">C gattii</span>, an emerging agent of cryptococcosis, was initially reported only in tropical and subtropical zones and rarely reported in China.<a class="elsevierStyleCrossRef" href="#bib0120"><span class="elsevierStyleSup">24</span></a> The patient infected with <span class="elsevierStyleItalic">C. gattii</span> had been worked in Cambodia and suffered before going back to China. So, this case of <span class="elsevierStyleItalic">C. gattii</span> cryptococcosis might have been imported.</p><p id="par0105" class="elsevierStylePara elsevierViewall">In previous reports, about 80% of the cryptococcosis cases were associated with HIV/AIDS in Europe and the United States.<a class="elsevierStyleCrossRefs" href="#bib0045"><span class="elsevierStyleSup">9,25</span></a> In contrast, in our study most of patients (71.4%) with cryptococcosis were not HIV-infected; moreover, 32.7% of the cryptococcosis patients had no underlying diseases, as shown in other reports from China.<a class="elsevierStyleCrossRefs" href="#bib0030"><span class="elsevierStyleSup">6,26</span></a> All of the 28 HIV-infected cryptococcosis patients with were male, and younger than the patients without HIV. There was no apparent sex difference in the cryptococcosis patients without HIV. The incidence rate of disseminated cryptococcosis, as well as the mortality rate, among HIV-infected patients were significantly higher than that in patients without HIV infection.</p><p id="par0110" class="elsevierStylePara elsevierViewall">In contrast to the findings of Lee et al., no relationship between MICs of antifungal agents and outcome of patients with cryptococcosis could be demonstrated in this study. The discrepancy might be due to different choices of treatment regimens.<a class="elsevierStyleCrossRef" href="#bib0070"><span class="elsevierStyleSup">14</span></a> In this study, four of the five patients infected with <span class="elsevierStyleItalic">C. neoformans</span> with higher MICs for fluconazole were still cured or improved following the regimen recommended by IDSA with amphotericin B and 5-flucytosine as the preferred agents for the induction therapy and fluconazole or voriconazole used in the consolidation and maintenance phases. Moreover, the patient infected with <span class="elsevierStyleItalic">C. neoformans</span> resistant to amphotericin B (MIC 8<span class="elsevierStyleHsp" style=""></span>μg/ml) responded to voriconazole. However, the shifting trend in MIC ranges of antifungal agents, especially fluconazole, warrants attention as it was also reported in other countries and might be related to the dose selection of fluconazole for effective therapy.<a class="elsevierStyleCrossRef" href="#bib0135"><span class="elsevierStyleSup">27</span></a> Hence, the dynamic real time surveillance of susceptibility for antifungal agents is necessary in clinic practice.</p><p id="par0115" class="elsevierStylePara elsevierViewall">This study has some limitations. It was a single center retrospective study conducted in a major teaching hospital in China. Hence, the results in this study are exploratory. In future, further investigations with larger samples including more hospitals in China will be necessary to generalize the results for the Chinese population.</p></span><span id="sec0085" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0115">Disclosure</span><p id="par0120" class="elsevierStylePara elsevierViewall">The authors report no conflicts of interest in this work.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:8 [ 0 => array:3 [ "identificador" => "xres1323581" "titulo" => "Abstract" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "abst0005" "titulo" => "Background" ] 1 => array:2 [ "identificador" => "abst0010" "titulo" => "Methods" ] 2 => array:2 [ "identificador" => "abst0015" "titulo" => "Results" ] 3 => array:2 [ "identificador" => "abst0020" "titulo" => "Conclusions" ] ] ] 1 => array:2 [ "identificador" => "xpalclavsec1220519" "titulo" => "Keywords" ] 2 => array:2 [ "identificador" => "sec0005" "titulo" => "Introduction" ] 3 => array:3 [ "identificador" => "sec0010" "titulo" => "Material and methods" "secciones" => array:8 [ 0 => array:2 [ "identificador" => "sec0015" "titulo" => "Cryptococcal isolates" ] 1 => array:2 [ "identificador" => "sec0020" "titulo" => "Antifungal susceptibility studies" ] 2 => array:2 [ "identificador" => "sec0025" "titulo" => "DNA extraction" ] 3 => array:2 [ "identificador" => "sec0030" "titulo" => "Identification of Cryptococcus species and variety" ] 4 => array:2 [ "identificador" => "sec0035" "titulo" => "Multilocus sequence typing (MLST) and mating type analysis" ] 5 => array:2 [ "identificador" => "sec0040" "titulo" => "Patient selection and data collection" ] 6 => array:2 [ "identificador" => "sec0045" "titulo" => "Statistical analysis" ] 7 => array:2 [ "identificador" => "sec0050" "titulo" => "Ethics and consent statements" ] ] ] 4 => array:3 [ "identificador" => "sec0055" "titulo" => "Results" "secciones" => array:3 [ 0 => array:3 [ "identificador" => "sec0060" "titulo" => "Microbiologic characterization of the cryptococcal isolates" "secciones" => array:1 [ 0 => array:2 [ "identificador" => "sec0065" "titulo" => "Trends in antifungal drug susceptibility of 217 cryptococcal isolates from 2013 to 2017" ] ] ] 1 => array:2 [ "identificador" => "sec0070" "titulo" => "Identification, multilocus sequence typing (MLST) and molecular types" ] 2 => array:2 [ "identificador" => "sec0075" "titulo" => "Patients’ characteristics" ] ] ] 5 => array:2 [ "identificador" => "sec0080" "titulo" => "Discussion" ] 6 => array:2 [ "identificador" => "sec0085" "titulo" => "Disclosure" ] 7 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2019-06-08" "fechaAceptado" => "2019-11-10" "PalabrasClave" => array:1 [ "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec1220519" "palabras" => array:5 [ 0 => "Cryptococcosis" 1 => "<span class="elsevierStyleItalic">Cryptococcus neoformans</span>" 2 => "Multilocus sequence typing (MLST)" 3 => "Antifungal susceptibility" 4 => "Human immunodeficiency virus (HIV)" ] ] ] ] "tieneResumen" => true "resumen" => array:1 [ "en" => array:3 [ "titulo" => "Abstract" "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0010">Background</span><p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">This study aims to explore the epidemiology, clinical profile and strain characteristics of cryptococcosis from 2013 to 2017 in a major teaching hospital in China.</p></span> <span id="abst0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0015">Methods</span><p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">Trends in antifungal drug susceptibility of 217 consecutive non-repetitive cryptococcal isolates collected from patients of an university hospital in China were analyzed between 2013 and 2017. Of those, 98 isolates were conserved for identification by internal transcribed spacer (ITS) sequencing and matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) system. Multilocus sequence typing (MLST) was used to designate molecular types. Clinical characteristics of the 98 patients with cryptococcosis during the period of 2013–2017 were retrospectively evaluated.</p></span> <span id="abst0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0020">Results</span><p id="spar0035" class="elsevierStyleSimplePara elsevierViewall">There was a trend for gradual increase in the MIC range of fluconazole was from 2013 to 2017. The conserved 98 clinical cryptococcal isolates included 97 C. <span class="elsevierStyleItalic">neoformans</span> and one <span class="elsevierStyleItalic">C. gattii</span>, and 90 (91.8%) isolates belonged to ST5 genotype VNI. Out of the 98 patients with cryptococcosis, 28 (28.6%) were HIV-infected and 32 (32.7%) had no underlying diseases. HIV-infected patients had higher mortality than HIV-uninfected patients (28.6% vs 14.3%, <span class="elsevierStyleItalic">p</span><span class="elsevierStyleHsp" style=""></span>=<span class="elsevierStyleHsp" style=""></span>0.147).</p></span> <span id="abst0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0025">Conclusions</span><p id="spar0040" class="elsevierStyleSimplePara elsevierViewall">Most of the patients with cryptococcosis were not HIV-infected in this study, while patients with HIV had a higher mortality. Reduced susceptibility to fluconazole was observed among <span class="elsevierStyleItalic">C. neoformans</span> isolates, most of them belonged to ST5 genotype VNI having an impact on the effective dose of fluconazole.</p></span>" "secciones" => array:4 [ 0 => array:2 [ "identificador" => "abst0005" "titulo" => "Background" ] 1 => array:2 [ "identificador" => "abst0010" "titulo" => "Methods" ] 2 => array:2 [ "identificador" => "abst0015" "titulo" => "Results" ] 3 => array:2 [ "identificador" => "abst0020" "titulo" => "Conclusions" ] ] ] ] "NotaPie" => array:1 [ 0 => array:3 [ "etiqueta" => "1" "nota" => "<p class="elsevierStyleNotepara" id="npar0010">Lan-fang Fang and Piao-piao Zhang contributed equally to this work.</p>" "identificador" => "fn0005" ] ] "multimedia" => array:4 [ 0 => array:8 [ "identificador" => "fig0005" "etiqueta" => "Fig. 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 2103 "Ancho" => 3169 "Tamanyo" => 207046 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0005" "detalle" => "Fig. " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Trends in fluconazole susceptibility of cryptococcal isolates from 2013 to 2017.</p>" ] ] 1 => array:8 [ "identificador" => "tbl0005" "etiqueta" => "Table 1" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0010" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:1 [ "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Antifungal agents \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">MIC range (μg/ml) \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">MIC<span class="elsevierStyleInf">50</span> \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">MIC<span class="elsevierStyleInf">90</span> \t\t\t\t\t\t\n \t\t\t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Amphotericin B \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0.5–8 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0.5 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0.5 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Fluconazole \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">1–16 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">2 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">4 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Flucytosine \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0.5–32 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">4 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">4 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Itraconazole \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0.06–1 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0.125 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0.25 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Voriconazole \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0.05–4 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0.064 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0.25 \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab2268596.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall"><span class="elsevierStyleItalic">In vitro</span> susceptibility to five antifungal agents of 217 cryptococcal isolates from an university hospital during a 5-year period (2013–2017).</p>" ] ] 2 => array:8 [ "identificador" => "tbl0010" "etiqueta" => "Table 2" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0015" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:1 [ "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">ST \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Genotype \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Variety \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">N (%) \t\t\t\t\t\t\n \t\t\t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">5 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">VNⅠ \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleItalic">var. grubii</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">90 (91.8%) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">31 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">VNⅠ \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleItalic">var. grubii</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">3 (3.1%) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">81 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">VNⅠ \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleItalic">var. grubii</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">2 (2.0%) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">359 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">VNⅠ \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleItalic">var. grubii</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">1 (1.0%) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">328 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">VGⅡ \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleItalic">C. gattii</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">1 (1.0%) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">326 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">VN Ⅳ \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleItalic">var. neoformans</span> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">1 (1.0%) \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab2268595.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">MLST and molecular type results of 98 clinical cryptococcal isolates.</p>" ] ] 3 => array:8 [ "identificador" => "tbl0015" "etiqueta" => "Table 3" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0020" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:2 [ "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Parameter \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">HIV-uninfected \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">HIV-infected \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Total \t\t\t\t\t\t\n \t\t\t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">No. of Patients \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">70 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">28 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">98 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Sex \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Male \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">57.1% (40/70) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">100% (28/28) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">69.4%(68/98) \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t"><span class="elsevierStyleHsp" style=""></span>Female \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">42.9% (30/70) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="